The landscape of cystic fibrosis (CF) has undergone a profound transformation following the advent of Cystic Fibrosis Transmembrane Regulator (CFTR) modulator therapies, which target the underlying genetic defect rather than solely managing symptoms. The gene discussed is CFTR; the disease is cystic fibrosis.